Literature DB >> 21923658

Epigenetics and psoriasis.

P Zhang1, Y Su, Q Lu.   

Abstract

Increasing evidence indicates that epigenetic mechanisms are involved in the pathogenesis of autoimmune rheumatic diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The pathogenesis of the organ-specific autoimmune disease psoriasis, however, remains poorly understood. Recent studies have shown that aberrant epigenetic patterns are present in patients with psoriasis, suggesting that epigenetic mechanisms may also be involved in this disease. Herein, we review relevant epigenetic findings associated with psoriasis, and provide clues and directions for further studies in this field.
© 2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21923658     DOI: 10.1111/j.1468-3083.2011.04261.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  13 in total

Review 1.  Epigenetics in Non-tumor Immune-Mediated Skin Diseases.

Authors:  M C Ovejero-Benito; E Daudén; Alejandra Reolid; E Muñoz-Aceituno; F Abad-Santos
Journal:  Mol Diagn Ther       Date:  2021-03-01       Impact factor: 4.074

2.  [Effect of aberrant H3K27me3 modification in promoter regions on cAMP response element modulator α expression in CD4+ T cells from patients with systemic lupus erythematosus].

Authors:  Qing Zhang; Shu Ding; Hui-Lin Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-12-20

3.  Study on Certain Biomarkers of Inflammation in Psoriasis Through "OMICS" Platforms.

Authors:  C Rodríguez-Cerdeira; A Molares-Vila; E Sánchez-Blanco; B Sánchez-Blanco
Journal:  Open Biochem J       Date:  2014-02-21

4.  Increased Set1 binding at the promoter induces aberrant epigenetic alterations and up-regulates cyclic adenosine 5'-monophosphate response element modulator alpha in systemic lupus erythematosus.

Authors:  Qing Zhang; Shu Ding; Huilin Zhang; Hai Long; Haijing Wu; Ming Zhao; Vera Chan; Chak-Sing Lau; Qianjin Lu
Journal:  Clin Epigenetics       Date:  2016-11-24       Impact factor: 6.551

Review 5.  Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis.

Authors:  Yu Ri Woo; Dae Ho Cho; Hyun Jeong Park
Journal:  Int J Mol Sci       Date:  2017-12-11       Impact factor: 5.923

6.  Multi-omics integration reveals molecular networks and regulators of psoriasis.

Authors:  Yuqi Zhao; Deepali Jhamb; Le Shu; Douglas Arneson; Deepak K Rajpal; Xia Yang
Journal:  BMC Syst Biol       Date:  2019-01-14

7.  Association of the DNMT3B -579G>T polymorphism with risk of thymomas in patients with myasthenia gravis.

Authors:  Fabio Coppedè; Roberta Ricciardi; Maria Denaro; Anna De Rosa; Carlo Provenzano; Emanuela Bartoccioni; Angelo Baggiani; Marco Lucchi; Alfredo Mussi; Lucia Migliore
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

8.  CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population.

Authors:  Liang Sun; Yunxiao Meng; Yanchen Xie; Hua Zhang; Zheng Zhang; Xiaoxia Wang; Bin Jiang; Wei Li; Yao Li; Ze Yang
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

9.  The crosstalk between IL-22 signaling and miR-197 in human keratinocytes.

Authors:  Galya Lerman; Moran Sharon; Raya Leibowitz-Amit; Yechezkel Sidi; Dror Avni
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

Review 10.  Biomarkers of An Autoimmune Skin Disease--Psoriasis.

Authors:  Shan Jiang; Taylor E Hinchliffe; Tianfu Wu
Journal:  Genomics Proteomics Bioinformatics       Date:  2015-09-08       Impact factor: 7.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.